Podcast
Dr Javed Butler: Vericiguat Guidelines
Dr. Javed Butler discusses the Class IIb recommendation for vericiguat in the ESC and ACC heart failure guidelines, highlighting the complexities behind guideline development. He explains how vericiguat's classification reflects the evolving understanding of worsening heart failure as a distinct entity, the limited trial data, and conservative decision-making by guideline committees. Dr. Butler emphasizes that the recommendation is not a downgrade of the therapy's value but rather a reflection of current evidence.
